¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Maf Transcription Factors, Large"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® large intestine ÇÑ±Û Å«Ã¢ÀÚ, ´ëÀå
¼³¸í   
  »ç¶÷ÀÇ ¼ÒÈ­±â°üÀº ¿©·¯ °¡Áö ±â°üÀ¸·Î ±¸¼ºµÇ¾î Àִµ¥, ÀÌÁߠâÀÚ°ü°è´Â ½Äµµ, À§, ÀÛÀºÃ¢Àڿ͠ūâÀڷΠ±¸¼ºµÇ¾î ÀÖ´Ù. ÀÔÀ¸·Î ¸Ô¾î¼­ Àß°Ô ºÐÇØµÈ À½½ÄÀº ½Äµµ¸¦ °ÅÃÄ, À§¿¡¼­ ´Ü¹éÁú µîÀÌ ¼ÒÈ­µÇ°í, »ùâÀÚ¿¡¼­ ÀÌÀÚ¿¡¼­ ºÐºñµÈ ¼ÒÈ­È¿¼Ò¿¡ ÀÇÇØ ¼ÒÈ­, ÀϺΠÈí¼öµÈ ÈÄ, ´ëºÎºÐÀÇ ¿µ¾çºÐÀº ÀÛÀºÃ¢ÀÚ¿¡¼­ Èí¼öµÈ´Ù. Å«Ã¢Àڴ ÁַΠ¹°°ú ¹Ì·®¿ø¼Ò, ÀüÇØÁúÀÇ Èí¼ö¿¡ ÀÌ¿ëµÇ¸ç, ÀÛÀºÃ¢ÀÚ¿¡¼­ ³»·Á¿Â ºÐºñ¹°À» ÀúÀåÇØ µÎ¾ú´Ù°¡ Å«Ã¢ÀÚ¸¦ °ÅÃÄ Ç×¹®À¸·Î ´ëº¯À» ¹è¼³ÇϰԠµÈ´Ù. Å«Ã¢Àڴ ±× À§Ä¡¿¡ µû¶ó 3ºÎºÐÀ¸·Î ±¸¼ºµÇ¾îÁö¸ç, ¸·Ã¢ÀÚ, Àß·èâÀÚ ±×¸®°í °ðâÀÚÀÌ´Ù. Àß·èâÀÚÀº ´Ù½Ã ¿À¸§Ã¢ÀÚ, °¡·ÎâÀÚ, ³»¸²Ã¢ÀڷΠÀÌ·ç¾îÁ® ÀÖÀ¸¸ç, À̰ÍÀº ±¸ºÒâÀÚ¶õ ¸»Àº SÀÚ ¸ð¾çÀ¸·Î ±Á¾îÁ® Àִٴ ¸»ÀÌ´Ù)À¸·Î À̾îÁ® °ðâÀÚÀåÀ» °ÅÃÄ Ç×¹®À¸·Î ¿¬°áµÈ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reverse transcription
    ¿ªÀü»ç
  • anaplastic large cell lymphoma
    ¿ªÇü¼ºÅ«¼¼Æ÷¸²ÇÁÁ¾
  • diffuse large B-cell lymphoma
    ±¤¹üÀ§Å«B¼¼Æ÷¸²ÇÁÁ¾
  • large artery
    Å«µ¿¸Æ, ´ëÇüµ¿¸Æ
  • large cell acanthoma
    Å«¼¼Æ÷°¡½Ã¼¼Æ÷Á¾, ´ë¼¼Æ÷±Ø¼¼Æ÷Á¾
  • large cell carcinoma
    ´ë¼¼Æ÷¾ÏÁ¾, Å«¼¼Æ÷¾ÏÁ¾
  • large intestine
    ūâÀÚ, ´ëÀå
  • large plaque parapsoriasis
    Å«ÆÇÀ¯»ç°Ç¼±, Å«ÆÇÀ¯»ç¸¶¸¥ºñ´ÃÁõ
  • large pyramidal neuron
    Å«ÇǶó¹Ìµå¼¼Æ÷, ´ëÃßü½Å°æ¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reverse transcription
    ¿ªÀü»ç
  • transcription
    ˟ȍ
  • atrophic large plaque parapsoriasis
    À§Ã༺ÆÇÀ¯»ç°Ç¼±
  • large artery
    Å«µ¿¸Æ, ´ëÇüµ¿¸Æ
  • large cell acanthoma
    Å«¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
  • large cell carcinoma
    Å«¼¼Æ÷¾ÏÁ¾, ´ë¼¼Æ÷¾ÏÁ¾
  • large intestine
    ūâÀÚ, ´ëÀå
  • large cell anaplastic lymphoma
    Å«¼¼Æ÷¿ªÇü¼º¸²ÇÁÁ¾
  • large pyramidal neuron
    Å«ÇǶó¹Ô¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Large intestine
    ūâÀÚ[´ëÀå]
  • artery,large elastic
    ź¼º ´ëµ¿¸Æ(÷¥àõ ÓÞÔÑØæ)
  • Insulin-like growth factors
    Àν¶¸°¾ç(å×)¼ºÀå(à÷íþ)È£¸£¸ó
  • psychological factors affecting medical condition
    ÀÇÇÐÀû»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • psychological factors affecting physical condition
    ½Åü»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • quality factors
    Ư¼º ¿ä¼Ò, Áú ¿ä¼Ò
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • macrophage activating factor (MAF)
    ´ë½Ä¼¼Æ÷ Ȱ¼ºÀÎÀÚ
  • chimeric transcription tactor
  • leader RNA primed transcription
    ¼±µµ RNA ½Ã¹ßÀü»ç
  • reverse transcription
    ¿ªÀü»ç
  • reverse transcription
    ¿ªÀü»ç(æ½ï®ÞÐ).
  • transcription
    ˟ȍ
  • transcription factor
    Àü»çÀÎÀÚ
  • transcription factor II
  • coagulation factors
    ÀÀ°íÀÎÀÚ(¡­ì×í­)
  • exogenous factors
    ¿ÜÀμº ¿ä¼Ò(èâì×àõ é©áÈ).
  • exogenous factors
    ¿ÜÀμº ¿ä¼Ò(¡­é©áÈ).
  • factors
  • psychological factors affecting medical condition
    ÀÇÇÐÀû»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • psychological factors affecting physical condition
    ½Åü»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • quality factors
    Ư¼º ¿ä¼Ò, Áú ¿ä¼Ò
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Large lymphocyte
    Å«¸²ÇÁ±¸
    [¿¾ ¿ë¾î] ´ëÀӯı¸
  • Large cell part
    Å«¼¼Æ÷ºÎºÐ
    [¿¾ ¿ë¾î] ´ë¼¼Æ÷ºÎ
  • LARGE INTESTINE
    ūâÀÚ [´ëÀå]
    [¿¾ ¿ë¾î] ´ëÀå
  • Large pyramidal neuron
    Å«ÇǶó¹Ô¼¼Æ÷
    [¿¾ ¿ë¾î] ´ëÃßü½Å°æ¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • large-angle X-ray diffraction
    ±¤°¢(ÎÆÊÇ) X-¼±È¸Àý(àÍüÞï¹)
  • MAF
    (å²) macrophage activating factor
  • fibroblast growth factors
    ¼¶À¯¾Æ¼¼Æ÷ ¼ºÀÚÀÎÀÚ (àéë«ä´á¬øàà÷íþì×í­)
  • suppressor factors
    ¾ï¾Ð(ÀÚ) ÀÎÀÚ(åääâ(í­)ì×í­)
  • asymmetric transcription
    ºÒ±Õµî Àü»ç (ÝÕгÔõï®ÞÐ)
  • coupled transcription-translation
    µ¿½Ã Àü»ç¹ø¿ª(ÔÒãÁï®ÞÐÛèæ»)
  • divergent transcription
    ºÐÁö Àü»ç(ÝÂò«ï®ÞÐ)
  • reverse transcription
    ¿ªÀü»ç(æ½ï®ÞÐ)
  • rRNA transcription unit
    rRNA Àü»ç ´ÜÀ§(ï®ÞÐÓ¤êÈ)
  • symmetric transcription
    ´ëĪÀü»ç (Óßöàï®ÞÐ)
  • transcription
    Àü»ç(ï®ÞÐ)
  • transcription initiation frquency
    Àü»ç°³½Ãºóµµ(ï®ÞÐËÒã·ÞºÓø)
  • transcription unit
    Àü»ç´ÜÀ§(ï®ÞÐÓ¤êÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • quality factors
    Ư¼º¿ä¼Ò, Áú¿ä¼Ò
  • transcription
    º¹»ç, Àü»ç
  • diffuse large cell lymphoma
    ¹Ì¸¸¼º Å«¼¼Æ÷ÀÓÆÄÁ¾
  • large cell
    ´ë¼¼Æ÷
  • large intestine
    ūâÀÚ, ´ëÀå
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
MAF macrophage activation factor; macrophage agglutinating factor; maximum atrial fragmentation; minimum...
ALL Acute Lymphocytic Leukemia
  ÇüÅÂÇÐÀû ºÐ·ù
    L1; Small, Homogenous(...
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
LGL large granular leukocyte; large granular lymphocyte; Lown-Ganong-Levine [syndrome]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MAF Macrophage Activating Factor
MAF Macrophage activation factor
MARE Maf recognition element
MAF Mouse amniotic fluid
AEF Allogeneic effect factors
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • controlling factors in facial growth
    ¾È¸é ¼ºÀåÀÇ Á¶Àý ¿äÀÎ
  • MAF
    ´ë½Ä ¼¼Æ÷ Ȱ¼ºÈ­ ÀÎÀÚ
    macro
  • reverse transcription
    ¿ªÀü»ç
  • angiotropic intravascular large cell lymphoma
    Ç÷°ü ¿µ¾ç¼º Ç÷°ü³» ´ë¼¼Æ÷ ¸²ÇÁÁ¾
  • atrophic large-plaque parapsoriasis
    À§Ã༺ ÆÇ
  • large amalgam tatto
    Å« ¾Æ¸»°¨ Âø»ö
  • large cell
    ´ë¼¼Æ÷
    ƯÁ¤ ÀÌÀ¯°¡ ÀÖ¾î
  • large cerebral artery
    ´ë³ú µ¿¸Æ
  • large head
    ´ëµÎ
    ¸Ó¸®°¡ ±Ù °Í.
  • large intestine
    ´ëÀå
    °øÀå, ȸÀå, ¸ÍÀå, Á÷Àå, °áÀåÀ¸·Î ³ª´µ¸ç ÁÖ·Î ¼öºÐÀ» Èí¼öÇÑ´Ù.
  • large nodular change
    °Å´ë °áÀý º¯È­
  • large salivary gland
    ´ë Ÿ¾×¼±
    ħÀÇ ºÐºñ¸¦ Á¿ìÇÏ´Â ¼±.
  • large surface form
    ³ÐÀº ¸éÀÇ ÇüÅÂ
  • large tumor
    Å« Á¾¾ç
  • mixed small and large cell lymphoma
    È¥ÇÕ¼º ´ë¼Ò¼¼Æ÷ ¸²ÇÁÁ¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
transcription factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
(12 Dec 1998)
transcription factors, tfii The so-called general transcription factors that bind to RNA polymerase II and that are required to initiate transcription. They include tfiia, tfiib, tfiid, tfiie, tfiif, tfiih, tfii-I, and tfiij. In vivo they apparently bind in an ordered multi-step process and/or may form a large preinitiation complex called RNA polymerase II holoenzyme.
(12 Dec 1998)
transcription factors, tfiii Factors that bind to RNA polymerase III and aid in transcription. They include the assembly factors tfiiia and tfiiic and the initiation factor tfiiib. All combine to form a preinitiation complex at the promotor that directs the binding of RNA polymerase III.
(12 Dec 1998)
MAF <abbreviation> Macrophage-activating factor.
(05 Mar 2000)
reverse transcription <molecular biology> The process of copying information found in RNA into DNA.
(09 Oct 1997)
transcription <molecular biology> Synthesis of RNA by RNA polymerases using a DNA template.
(18 Nov 1997)
transcription factor <molecular biology> Protein required for recognition by RNA polymerases of specific stimulatory sequences in eukaryotic genes.
Several are known that activate transcription by RNA polymerase II when bound to upstream promoters.
Transcription of the 5S RNA gene in Xenopus by RNA polymerase III is dependent on a 40 kD protein TFIIIA that binds to a regulatory site in the centre of the gene and was the first protein found to exhibit the metal binding domains known as zinc fingers.
(17 Mar 1998)
transcription factor ap-1 A multiprotein complex composed of the products of c-jun and c-fos proto-oncogenes. These proteins must dimerise in order to bind to the ap-1 recognition site, also known as the tpa-responsive element (tre). Ap-1 controls both basal and inducible transcription of several genes.
(12 Dec 1998)
transcription factor, sp1 Promoter-specific RNA polymerase II transcription factor that binds to the gc box, one of the upstream promoter elements (upe) in mammalian cells. The binding of sp1 is necessary to initiate transcription in the promoters of a variety of cellular and viral genes including c-ha-ras and HIV.
(12 Dec 1998)
transcription, genetic The transfer of genetic information from DNA to messenger RNA by DNA-directed RNA polymerase. It includes reverse transcription and transcription of early and late genes expressed early in an organism's life cycle or during later development.
(12 Dec 1998)
transcription unit <molecular biology> A region of DNA that is transcribed to produce a single primary RNA transcript, i.e. A newly synthesised RNA molecule that has not been processed.
Transcription units can be mapped by kinetic studies of RNA synthesis and in some instances directly visualised by electron microscopy.
(17 Mar 1998)
erythroid transcription factor <molecular biology> Transcription factor that binds to regulatory regions of genes expressed in erythroid cells.
(18 Nov 1997)
anaplastic large cell lymphoma <tumour> A form of lymphoma characterised by anaplasia of cells, sinusoidal growth, and immunoreactivity with CD30 (Ki-1 or Ber-H2).
Synonym: Ki-1+ lymphoma.
(05 Mar 2000)
bilateral large kidneys <radiology> Autosomal dominant (adult) polycystic disease, lymphoma Cf: other urographic patterns
(12 Dec 1998)
carcinoma, large cell A tumour of undifferentiated (anaplastic) cells of large size. It is usually bronchogenic.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Maf Transcription Factors, Large - »õâ A family of high molecular weight Maf transcription factors that contain distinct activation domains.
    Synonyms :
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transcription
    ˟ȍ
  • electrical transcription
    ³ìÀ½ ¹æ¼Û¿ä(·¹ÄÚµå,Å×ÀÌÇÁ);³ìÀ½
  • transcription
    ÇÊ»ç;¸ð»ç;º¹»ç;¹Ù²ã ¾¸;Àü»ç;¹Ù²ã¾´ °Í
  • at large
    ´ë°³
  • large
    Å«,³ÐÀº,´ë±Ô¸ðÀÇ,µµ·®ÀÌ ³ÐÀº,³Ê±×·¯¿î,±¤¹üÀ§ÇÑ,¼øÇ³ÀÇ
  • congressman-at-large
    ÀüÁÖ 1±¸ ¼±ÃâÀÇ ÇÏ¿ø ÀÇ¿ø
  • large
    Å«;´Ù¼öÀÇ;°ü´ëÇÑ;¸·¿¬È÷;as ~ as life ½Ç¹° Å©±âÀÇ;be ~ of limb ¼Õ¹ßÀÌ Å«
  • large
    Å©°Ô;´ë´ëÀûÀ¸·Î;ÀÚ¼¼È÷;°ú´ëÇϰÔ
  • large
    at ~ »ó¼¼È÷;ÃæºÐÈ÷;³Î¸®;ÀϹÝÀûÀ¸·Î;¸·¿¬È÷;in (the) ~ ´ë±Ô¸ð·Î
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á